UNICA IRIS Institutional Research Information System

MANTOVANI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 34.283
NA - Nord America 4.399
AS - Asia 1.661
SA - Sud America 192
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 32
OC - Oceania 1
Totale 40.682
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 33.292
US - Stati Uniti d'America 4.279
CN - Cina 637
SG - Singapore 592
UA - Ucraina 276
SE - Svezia 201
BR - Brasile 146
GB - Regno Unito 123
VN - Vietnam 118
DE - Germania 104
FI - Finlandia 101
FR - Francia 88
HK - Hong Kong 75
CA - Canada 66
KR - Corea 59
IN - India 56
BD - Bangladesh 19
RU - Federazione Russa 18
BE - Belgio 16
IQ - Iraq 15
ES - Italia 14
JP - Giappone 13
AR - Argentina 11
MX - Messico 11
PK - Pakistan 11
PL - Polonia 11
ZA - Sudafrica 11
JM - Giamaica 10
NL - Olanda 10
TR - Turchia 10
CR - Costa Rica 9
PH - Filippine 9
IR - Iran 8
CL - Cile 7
EC - Ecuador 5
NI - Nicaragua 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
VE - Venezuela 5
AT - Austria 4
CO - Colombia 4
LT - Lituania 4
MY - Malesia 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
BO - Bolivia 3
CG - Congo 3
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
SA - Arabia Saudita 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
GP - Guadalupe 2
HN - Honduras 2
ID - Indonesia 2
IE - Irlanda 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 40.568
Salva come PNG Salva come JPEG
Città #
Cagliari 32.214
Uta 856
Ashburn 513
Fairfield 406
Singapore 324
San Jose 294
Woodbridge 265
Chandler 230
Houston 206
Seattle 191
Nyköping 179
Boardman 158
Dallas 153
Wilmington 153
Jacksonville 152
Cambridge 151
Ann Arbor 149
Beijing 119
Los Angeles 83
Santa Clara 77
Hong Kong 65
Dearborn 64
Council Bluffs 59
Shanghai 53
Helsinki 51
Ho Chi Minh City 51
Seoul 51
New York 50
Boston 49
Nanjing 49
Lauterbourg 48
Guangzhou 36
Hefei 34
Buffalo 31
London 28
Hanoi 24
Toronto 24
Changsha 22
The Dalles 22
Pune 21
San Diego 21
Shenyang 18
Milan 17
Brussels 16
Dundalk 15
Munich 15
Rome 15
Tianjin 15
Chicago 14
Nanchang 12
Jiaxing 11
Redondo Beach 11
São Paulo 10
Atlanta 9
Jinan 9
Kingston 9
Montreal 9
Redwood City 9
Baghdad 8
Norwalk 8
Phoenix 8
Princeton 8
Tokyo 8
Chennai 7
Orange 7
San Francisco 7
San Mateo 7
Ankara 6
Auburn Hills 6
Belo Horizonte 6
Columbus 6
Hangzhou 6
Kunming 6
North Bergen 6
Orem 6
Richmond 6
Turku 6
Verona 6
Warsaw 6
Barcelona 5
Brandizzo 5
Brooklyn 5
Denver 5
Hebei 5
Managua 5
Poplar 5
Rio de Janeiro 5
San José 5
Shenzhen 5
Stockholm 5
Wuhan 5
Augusta 4
Aurora 4
Chongqing 4
Colombo 4
Curitiba 4
Detroit 4
Frankfurt am Main 4
Haiphong 4
Kilburn 4
Totale 38.176
Salva come PNG Salva come JPEG
Nome #
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.594
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.213
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 2.073
Advances in pharmacologic strategies for cancer cachexia 1.912
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.803
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.746
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 1.523
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 984
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 983
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 961
null 936
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 931
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 921
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 842
null 819
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 792
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 765
Current medications for cancer cachexia 740
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 719
null 681
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 644
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 630
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 618
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 579
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate 558
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress 556
Role of proinflammatory cytokines and leptin in cancer-related anorexia/cachexia. Metabolic abnormalities and therapeutic approaches = Ruolo delle citochine infiammatorie e della leptina nell'anoressia/cachessia neoplastica. Aspetti metabolici e terapeutici 548
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation 543
Efficacy, compliance and prognostic significance of a comprehensive geriatric assessment in the geriatric cancer patient = Efficacia, applicabilità e significato prognostico di una valutazione geriatrica multidimensionale nel paziente oncologico anziano 535
null 529
Cisplatin induces serotonin release from human peripheral blood mononuclear cells of cancer patients and methylprednisolone inhibits this effect 524
Medroxyprogesterone acetate reduces the In vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 524
Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients 520
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation 512
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: A tentative quantitative evaluation of organ preservation and clinical response 503
Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients 497
Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC 484
Tumor-associated lymphomonocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokynes 483
Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions 481
Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 470
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response 443
Anorexia/Cachexia and oxidative stress in cancer patients = Anoressia/Cachessia e stress ossidativo nei pazienti con cancro 432
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG) 382
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial 343
Peripheral blood lymphocyte response to exogenous interleukin 2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer 337
Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies 297
[p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors] 266
Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies 190
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial 165
Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin 163
Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy 159
Immunologic assessment determined by response to IL-2 and immunophenotyping of tumor-infiltrating lymphocytes, of invaded and non invaded lymph nodes and of peripheral blood lymphocytes from twenty-one patients with primary laryngeal cancer 146
Lack of correlation between defective cell-mediated immunity and levels of secreted or circulating cytokines in a study of 90 cancer patients 145
Preovulatory human follicular fluid in vitro inhibits interleukin (IL)- 1α, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes 144
Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55-p75 subunit expression in patients with cancer of different sites 132
[The immunological assessment of a combined therapeutic approach (chemo- + radiotherapy +/- surgery) including immunotherapy in neoplasms of the head and neck area at an advanced stage] 124
Evidence that granulosa cells inhibit interleukin-1α and interleukin-2 production from follicular lymphomonocytes 91
Medical imaging: a segmentation algorithm 47
Totale 40.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.989
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022972 0 0 0 0 154 83 60 91 118 102 158 206
2022/20232.436 185 235 180 175 175 290 71 461 164 146 211 143
2023/20243.628 245 128 131 271 356 660 389 235 196 352 304 361
2024/20254.739 389 796 834 760 493 783 278 55 91 73 102 85
2025/20262.558 161 128 330 225 253 157 455 111 211 325 141 61
2026/2027883 32 178 282 329 62 0 0 0 0 0 0 0
Totale 40.682